mhurhangee/ep-ind-claims huggingface dataset:
A method for retrieving a bearer context, wherein the method comprises: receiving, by a serving gateway for user plane, SGW-U, a data packet, and matching context information of a corresponding bearer according to a tunnel endpoint identifier, TEID, carried in the data packet; sending a trigger message to a serving gateway for control plane, SGW-C, if the SGW-U determines, through matching, that the SGW-U does not comprise the context information of the bearer, wherein the trigger message carries the TEID, and the trigger message is used by the SGW-C to obtain the context information of the bearer according to the TEID; receiving a reestablish bearer context message from the SGW-C, wherein the reestablish bearer context message carries the context information of the bearer; and sending the data packet according to the context information of the bearer. receiving, by a serving gateway for user plane, SGW-U, a data packet, and matching context information of a corresponding bearer according to a tunnel endpoint identifier, TEID, carried in the data packet; sending a trigger message to a serving gateway for control plane, SGW-C, if the SGW-U determines, through matching, that the SGW-U does not comprise the context information of the bearer, wherein the trigger message carries the TEID, and the trigger message is used by the SGW-C to obtain the context information of the bearer according to the TEID; receiving a reestablish bearer context message from the SGW-C, wherein the reestablish bearer context message carries the context information of the bearer; and sending the data packet according to the context information of the bearer.
A linear sensor comprising a sleeve, a pin, which contains a permanent magnet and is linearly displaceably supported in the sleeve, and a magnetic field sensor, which is fastened on the sleeve and is used to detect a displacement of the permanent magnet, wherein the pin is guided with a substantially cylindrical guide, characterized in that the pin comprises a magnet holder or a pin holder, the magnet holder or pin holder is rigidly connectable to a measurement object and has at least three spring elements, the spring elements are disposed, on the side thereof facing the magnetic field sensor, on a substantially annular element, and the pin has a thickening on the end thereof facing away from the magnetic field sensor, by means of which the end rests against the annular element.
An upper body structure of a vehicle, comprising: left and right roof side rails each including a rail outer member located laterally outside the vehicle and a rail inner member located laterally inside the vehicle and forming a closed cross-section structure with the rail outer member, the left and right roof side rails extending in a longitudinal direction along left and right sides of a roof of the vehicle; a roof cross member extending across the left and right roof side rails, with both ends of the roof cross member connected individually to the left and right roof side rails; and a reinforcing member disposed in the closed cross-section structure of the left and right roof side rails at a position where each roof side rail is connected to the roof cross member, wherein the rail outer member includes an upper outer wall and a lower outer wall which are curved and bent to protrude laterally to the outside of the vehicle to form a ridgeline extending longitudinally along a boundary between the upper outer wall and the lower outer wall said upper body structure of a vehicle being characterized in that the reinforcing member includes a base bonded to the upper outer wall and the lower outer wall, a facing plate facing the rail inner member, and a supporting wall standing on the base to support the facing plate, and the facing plate is at least partially located on the laterally inside of a plane passing through two edge lines (62, 64) of the upper outer wall and the lower outer wall, each edge line opposing the ridgeline. left and right roof side rails each including a rail outer member located laterally outside the vehicle and a rail inner member located laterally inside the vehicle and forming a closed cross-section structure with the rail outer member, the left and right roof side rails extending in a longitudinal direction along left and right sides of a roof of the vehicle; a roof cross member extending across the left and right roof side rails, with both ends of the roof cross member connected individually to the left and right roof side rails; and a reinforcing member disposed in the closed cross-section structure of the left and right roof side rails at a position where each roof side rail is connected to the roof cross member, wherein the rail outer member includes an upper outer wall and a lower outer wall which are curved and bent to protrude laterally to the outside of the vehicle to form a ridgeline extending longitudinally along a boundary between the upper outer wall and the lower outer wall said upper body structure of a vehicle being characterized in that the reinforcing member includes a base bonded to the upper outer wall and the lower outer wall, a facing plate facing the rail inner member, and a supporting wall standing on the base to support the facing plate, and the facing plate is at least partially located on the laterally inside of a plane passing through two edge lines (62, 64) of the upper outer wall and the lower outer wall, each edge line opposing the ridgeline.
A method for the production of recombinant C.histolyticum collagenase comprising the steps of: a) designing a nucleotide sequence optimized for the expression of said collagenase of C. histolyticum; b) introducing, in an inducible expression vector, an oligonucleotide sequence coding for a fusion protein, wherein said oligonucleotide sequence consists in said optimized sequence fused to a nucleotide sequence coding for a soluble polypeptide and wherein said oligonucleotide sequence is operatively linked to an inducible promoter sequence, a transcription start sequence and a termination sequence; c) transforming a bacterial strain defective in the expression of endogenous proteases with said expression vector; d) culturing said transformed bacterial strain at a temperature comprised in a range of 28-32°C extremes included; e) inducing the expression of said fusion protein by adding a suitable inductor in said bacterial strain; f) extracting the fusion protein obtained at point e), and g) purifying said fusion protein; wherein said method provides a yield higher than 140 mg/l of culture of said collagenase in soluble and enzymatically active form, wherein said collagenase is a fusion protein MBP- C. histolyticum ColG and MBP- C. histolyticum ColH and wherein said soluble polypeptide is a "purification tag" selected in the group consisting of: poly/hexahistidine tag, glutathione-S-transferase, thioredoxin, protein A fragment of Staphylococcus aureus, peptide with affinity for streptavidin (Strep-tag), flag peptide. a) designing a nucleotide sequence optimized for the expression of said collagenase of C. histolyticum; b) introducing, in an inducible expression vector, an oligonucleotide sequence coding for a fusion protein, wherein said oligonucleotide sequence consists in said optimized sequence fused to a nucleotide sequence coding for a soluble polypeptide and wherein said oligonucleotide sequence is operatively linked to an inducible promoter sequence, a transcription start sequence and a termination sequence; c) transforming a bacterial strain defective in the expression of endogenous proteases with said expression vector; d) culturing said transformed bacterial strain at a temperature comprised in a range of 28-32°C extremes included; e) inducing the expression of said fusion protein by adding a suitable inductor in said bacterial strain; f) extracting the fusion protein obtained at point e), and g) purifying said fusion protein;
A composition for use in the treatment of cancer, comprising an antibody binding ABCB5 having an immunoglobulin heavy chain variable domain with a CDR1-H1, a CDR2-H2, and a CDR3-H3 amino acid sequence of SEQ ID NO: 3, 4 and 5, and an immunoglobulin light chain variable domain with a CDR1-L1, a CDR2-L2, and a CDR3-L3 amino acid sequence of SEQ ID NO: 6, 7 and 8.
A method to implement an adaptive multicast data rate transmission selection comprising: transmitting multicast data frames at a first data rate; receiving a predetermined number of successive acknowledgments of successful frame reception using the first data rate; increasing the first data rate to a second data rate for a period of time in response to the number of acknowledgements; transmitting multicast data frames at the second data rate; determining one frame loss during said period of time; and determining a third multicast data rate responsive to the multicast frame loss; wherein the step of determining a third multicast data rate responsive to the multicast frame loss comprises using the second data rate as a new multicast data rate if the frame loss rate is less than a threshold, and wherein the threshold is a probability threshold based upon a ratio of transmission times needed for transmitting a multicast frame at the second data rate and at the first data rate. transmitting multicast data frames at a first data rate; receiving a predetermined number of successive acknowledgments of successful frame reception using the first data rate; increasing the first data rate to a second data rate for a period of time in response to the number of acknowledgements; transmitting multicast data frames at the second data rate; determining one frame loss during said period of time; and determining a third multicast data rate responsive to the multicast frame loss;
A segmented armature assembly (1, W) for a wind turbine generator, comprising - an annular armature comprising at least six armature segments separated by gaps; - winding sets (s1, s2) of two multi-phase winding systems (S1, S2), wherein each winding set (s1, s2) comprises one winding for each phase of a specific multi-phase winding system (S1, S2); characterized by a first winding distribution, wherein each armature segment carries winding sets (s1, s2) of one winding system only such that any one stator segment is flanked by two armature segments, each carrying only winding sets (s1, s2) of the other winding system and wherein the winding sets (s1, s2) on either side of a gap are a mirror image of the winding sets (s1, s2) on either side of the other two closest gaps; or characterized by a second winding distribution, wherein each armature segment carries an alternating arrangement of an even number of winding sets (s1, s2), and wherein the arrangement of winding sets (S1, S2) carried by one armature segment is a mirror image of the arrangement of winding sets (S1, S2) carried by the adjacent armature segments. - an annular armature comprising at least six armature segments separated by gaps; - winding sets (s1, s2) of two multi-phase winding systems (S1, S2), wherein each winding set (s1, s2) comprises one winding for each phase of a specific multi-phase winding system (S1, S2);
A combination comprising: (i) a pharmaceutically effective amount of Compound No. 1 or a pharmaceutically acceptable salt thereof and (ii) at least one additional therapeutic agent, wherein the at least one additional therapeutic agent comprises osimertinib or a pharmaceutically acceptable salt thereof, for the use for the treatment of non-small cell lung carcinoma (NSCLC) in a subject, wherein the NSCLC is EGFR-TKI-resistant NSCLC and/or the NSCLC is associated with an EGFR mutation. (i) a pharmaceutically effective amount of Compound No. 1 or a pharmaceutically acceptable salt thereof and (ii) at least one additional therapeutic agent, wherein the at least one additional therapeutic agent comprises osimertinib or a pharmaceutically acceptable salt thereof, for the use for the treatment of non-small cell lung carcinoma (NSCLC) in a subject, wherein the NSCLC is EGFR-TKI-resistant NSCLC and/or the NSCLC is associated with an EGFR mutation.
A round baler, whose bale chamber is formed circumferentially by circumferential compression elements (6 to 9), having at least one wrapping device (18, 31, 37) having a pair of preferred rollers (21, 31) for wrapping a round bale with wrapping material which can be introduced into the latter by means of at least one further drivable feeding element (25, 30, 36) through an insertion gap in the baling chamber, characterised in that the feeding element is a conveyor roller or a conveyor belt and the direction of rotation of said conveyor roller or belt can be reversed.
A delivery device comprising a composition comprising a eukaryotic microorganism having an 18S sequence, wherein the 18S sequence has at least 97 % identity to the sequence set forth in SEQ ID NO:1, wherein the microorganism is capable of producing a lipid composition, and wherein the lipid composition comprises n-3 DHA, n-6 DPA, and/or n-3 EPA.
A single-chain Alphabody library comprising at least 100 different-sequence single-chain Alphabody polypeptides, each of said single-chain Alphabody polypeptides having the general formula HRS1-L1-HRS2-L2-HRS3, wherein - each of HRS1, HRS2 and HRS3 is independently a heptad repeat sequence consisting of 2 to 7 consecutive heptad repeat units, at least 50% of all heptad a- and d-positions are occupied by isoleucine residues, each HRS starts and ends with an aliphatic or aromatic amino acid residue located at either a heptad a- or d-position, and HRS1, HRS2 and HRS3 together form a triple-stranded, alpha-helical, coiled coil structure; and - each of L1 and L2 is independently a linker fragment, which covalently connects HRS1 to HRS2 and HRS2 to HRS3, respectively, and consisting of at least 4 amino acid residues, preferably at least 50% of which are selected from the group proline, glycine, serine; wherein said Alphabody polypeptides differ from each other in at least one of a defined set of 5 to 20 variegated amino acid residue positions, and wherein at least 70% but not all of said variegated amino acid residue positions are located either: (i) at heptad e-positions in a first alpha-helix of the Alphabody polypeptides and at heptad g-positions in a second alpha-helix, and optionally at heptad b-positions in said first alpha-helix of the Alphabody polypeptides and/or at heptad c-positions in said second alpha-helix of the Alphabody polypeptides, or (ii) at heptad b-, c- and f-positions in one alpha-helix of the Alphabody polypeptides, or (iii) at positions in a linker fragment connecting two consecutive alpha-helices of the Alphabody polypeptides. - each of HRS1, HRS2 and HRS3 is independently a heptad repeat sequence consisting of 2 to 7 consecutive heptad repeat units, at least 50% of all heptad a- and d-positions are occupied by isoleucine residues, each HRS starts and ends with an aliphatic or aromatic amino acid residue located at either a heptad a- or d-position, and HRS1, HRS2 and HRS3 together form a triple-stranded, alpha-helical, coiled coil structure; and - each of L1 and L2 is independently a linker fragment, which covalently connects HRS1 to HRS2 and HRS2 to HRS3, respectively, and consisting of at least 4 amino acid residues, preferably at least 50% of which are selected from the group proline, glycine, serine; (i) at heptad e-positions in a first alpha-helix of the Alphabody polypeptides and at heptad g-positions in a second alpha-helix, and optionally at heptad b-positions in said first alpha-helix of the Alphabody polypeptides and/or at heptad c-positions in said second alpha-helix of the Alphabody polypeptides, or (ii) at heptad b-, c- and f-positions in one alpha-helix of the Alphabody polypeptides, or (iii) at positions in a linker fragment connecting two consecutive alpha-helices of the Alphabody polypeptides.
Steam boiler liquid separator for a steam boiler through which steam flows vertically, wherein a number of swirl vanes are arranged about a shaft in a pipe section, wherein each swirl vane is connected to the pipe section, wherein the swirl vanes are shaped such that a rotational movement is imparted to a flow of steam through the pipe section in addition to its longitudinal movement through the pipe section, characterized in that the pipe section has a plurality of pipe segments, in that a shaft has a plurality of shaft segments, in that each swirl vane is connected to a pipe segment and to a shaft segment to form a liquid separator segment (12, 14, 16, 18), in that the shaft segments are connected positively and detachably to a shaft segment holder, and in that the shaft segments are held in their structurally intended position by the positive connection.
An apparatus comprising: a conducting probe (101, 204) configured to couple with an electrical conductor of an electrical terminal of a power device; a sensor (104, 205) in contact with the conducting probe; and a controller circuit (107, 207) electrically coupled to the sensor, wherein the controller circuit is configured to monitor values of the sensor, and the controller circuit is configured to, when the values of the sensor are determined to be abnormal, initiate/command the lowering of the current flowing through the electrical conductor; wherein the conducting probe (101, 204) comprises a recess configured to receive a jumper bridge, wherein the jumper bridge is inserted in the recess, the conducting probe (101, 104) is electrically coupled to the electrical terminal and the jumper bridge, thereby electrically coupling the electrical terminal and the jumper bridge. a conducting probe (101, 204) configured to couple with an electrical conductor of an electrical terminal of a power device; a sensor (104, 205) in contact with the conducting probe; and a controller circuit (107, 207) electrically coupled to the sensor, wherein the controller circuit is configured to monitor values of the sensor, and the controller circuit is configured to, when the values of the sensor are determined to be abnormal, initiate/command the lowering of the current flowing through the electrical conductor; wherein the conducting probe (101, 204) comprises a recess configured to receive a jumper bridge, wherein the jumper bridge is inserted in the recess, the conducting probe (101, 104) is electrically coupled to the electrical terminal and the jumper bridge, thereby electrically coupling the electrical terminal and the jumper bridge.
Method for arbitrating access to a memory shared between at least a first interface and a second interface, comprising triggering a count having a maximum count time, in response to a memory access request from the second interface while current access to the memory is granted to the first interface, and authorising access to the memory for the second interface at the end of occupancy of the access granted to the first interface if the end of occupancy occurs before the end of the maximum count time or otherwise at the end of said maximum count time. triggering a count having a maximum count time, in response to a memory access request from the second interface while current access to the memory is granted to the first interface, and authorising access to the memory for the second interface at the end of occupancy of the access granted to the first interface if the end of occupancy occurs before the end of the maximum count time or otherwise at the end of said maximum count time.
A composition: (i) which is, or which comprises, a fungal fermented cheese comprising a population of cells and/or spores of a food fungus; (ii) comprising an extract from said fungal fermented cheese of (i); and/or (iii) which is a fortified food or beverage, a food additive, a dietary supplement, a neutraceutical product, a pharmaceutical product, a topical dermatological product or a topical cosmetic product which comprises a fungal fermented cheese of (i) or the extract of (ii), for use in the prevention or treatment of infection, inflammation and/or inflammatory damage, wherein the fungus used in the production of said cheese is a fungus of the Penicillium genus. (i) which is, or which comprises, a fungal fermented cheese comprising a population of cells and/or spores of a food fungus; (ii) comprising an extract from said fungal fermented cheese of (i); and/or (iii) which is a fortified food or beverage, a food additive, a dietary supplement, a neutraceutical product, a pharmaceutical product, a topical dermatological product or a topical cosmetic product which comprises a fungal fermented cheese of (i) or the extract of (ii),
A head mounted display, HMD, device, comprising: a color information obtaining unit configured to obtain color information regarding a lens arranged at a portion of the HMD device, wherein color information regarding a lens includes Red-Green-Blue, RGB, values for indicating a color of the lens; and a control unit configured to determine a color of the lens based on the color information, modify color of an image to a predetermined color corresponding to the color of the lens and output the modified image via a display unit arranged at the HMD device; the HMD device characterized in that the control unit is further configured to determine a complementary color corresponding to the color of the lens as the predetermined color for modifying the color of the image. a color information obtaining unit configured to obtain color information regarding a lens arranged at a portion of the HMD device, wherein color information regarding a lens includes Red-Green-Blue, RGB, values for indicating a color of the lens; and a control unit configured to determine a color of the lens based on the color information, modify color of an image to a predetermined color corresponding to the color of the lens and output the modified image via a display unit arranged at the HMD device; the HMD device characterized in that the control unit is further configured to determine a complementary color corresponding to the color of the lens as the predetermined color for modifying the color of the image.